Precision Medicine for L/GCMN and Melanoma 2

Recruiting now

Conditions studied: Melanoma (Skin Cancer), Nevi and Melanomas, Congenital Melanocytic Nevus

In brief

The primary objective is to evaluate the possibility of using minimally and non-invasive technologies (skin patch and breath analyzer) based on the detection of volatile organic compounds (VOCs) for the early identification of metastases. The secondary objective is to evaluate the usability of these technologies in the follow up of high-risk melanoma patients.

Key facts

Study ID

NCT06605443

Run by

Fundacion Clinic per a la Recerca Biomédica

People needed

100

Starts

2025-01-01

Expected to finish

2026-12-01

Last updated by the study team

2025-02-27

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Be over 18 years old
• Have a histopathological confirmed melanoma diagnosis (stage II, III or IV AJCC)

You may not qualify if…

• Not signing the informed consent form
• Present other cancers or chronic diseases (such as diabetes, asthma, etc.), which may affect the volatile organic compound profiles

Where it is running

• Hospital Clínic Barcelona — Barcelona, Spain (enrolling)
• Hospital Clínic Barcelona — Barcelona, Spain (enrolling)
• Hospital Clínic de Barcelona (Dermatology service) — Barcelona, Spain

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.